ATHERSYS INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ATHERSYS INC and buy or sell other stocks, ETFs, and their options commission-free!

About ATHXQ

Athersys, Inc. is a biotechnology company, which focuses on the field of regenerative medicine. It engages in the discovery and development of therapies designed to extend and enhance the quality of human life. 

CEO
Daniel A. Camardo, MBA
CEODaniel A. Camardo, MBA
Employees
24
Employees24
Headquarters
Cleveland, Ohio
HeadquartersCleveland, Ohio
Founded
1995
Founded1995
Employees
24
Employees24

ATHXQ Key Statistics

Market cap
6.17K
Market cap6.17K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
698.56
Average volume698.56
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.001
52 Week high$0.001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

ATHERSYS INC(ATHXQ) stock is priced at $0.00, giving the company a market capitalization of 6.17K.

On 2026-02-02, ATHERSYS INC(ATHXQ) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for ATHERSYS INC(ATHXQ) stock has reached 0, versus its average volume of 698.56.

Over the past 52 weeks, ATHERSYS INC(ATHXQ) stock has traded between a high of $0.00 and a low of $0.00.

Over the past 52 weeks, ATHERSYS INC(ATHXQ) stock has traded between a high of $0.00 and a low of $0.00.

People also own

Based on the portfolios of people who own ATHXQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.